At age 75, the results of this research will probably arrive too late to help me (10 years?), but hopefully younger AF sufferers can look forward much more positively to an individualised approach to their use of anticoagulants.
And think of the improvement that will occur in Apple Watches and other self-monitoring health devices in these next possibly 10 years.
I know which side of the trial I'm hoping is clearly superior, but regardless of the outcome of the trial, we will all know a lot more about the facts surrounding the use of DOACs, as well as stroke and bleed risks.
Here's a link to a report of the new research ...